Neuroscience News

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease, but which also carry safety risks according to Knight Initiative for Brain Resilience affiliate Mike Greicius and others.

At the 2024 Neuro-omics Symposium, early-stage research funded by Wu Tsai Neuro's Big Ideas in Neuroscience program revealed exciting progress at the intersection of genomics and AI.

New software developed by the NeuroPlant Big Ideas in Neuroscience initiative turns an ordinary flatbed scanner and collection of nematode worms into a DIY platform to sniff out both beneficial and harmful plant-based molecules.

Researchers are closer to having a more precise method for efficiently treating depression, a new study suggests.

Experts at Stanford Medicine Children’s Health helped conduct clinical trials for the new therapy, which gives kids with X-linked adrenoleukodystrophy, or ALD, a functioning copy of the abnormal gene.

Ten early career neuroscientists received the prestigious award from The McKnight Endowment Fund for Neuroscience.

This week, we talk with Michelle Monje and Rob Malenka about recent findings on the role of myelin plasticity in opioid addiction.

In an analysis of more than 2 million patient records, researchers discovered that people taking angiotensin receptor blockers for high blood pressure were less likely to develop epilepsy.

Brain imaging, known as functional MRI, combined with machine learning can predict a treatment response based on one’s depression “biotype.”

To advance neuroscience research using EEG and TMS technologies, the Koret Human Neurosciences Community Lab has awarded its inaugural Human Neuroscience Pilot Grants to ten innovative research projects.

Why do our brains get worse at learning as we get older, and what can we do about it? Institute affiliate Carla Shatz discusses our brain's capacity for change on this podcast episode.

Wu Tsai Neuro affiliate Michelle Monje and team discovered that adaptive myelination, a form of brain plasticity, contributes to drug addiction. A single morphine dose in mice triggered myelination in reward-related brain circuits, reinforcing drug-seeking behavior. Blocking this myelination prevented addiction, highlighting potential new treatment strategies.

A study in mice by Wu Tsai Neuro affiliate Michelle Monje and team has found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids.

In a new, large-scale study of sleep behavior, Wu Tsai Neuro affiliate Jamie Zeitzer and team found that night owls don’t thrive late at night.

Most Parkinson’s disease patients struggle with speech problems. New research by Stanford Medicine scientists uncovers the brain connections that could be essential to preserving speech.

A research team at Stanford’s Wu Tsai Neurosciences Institute has made a major stride in using AI to replicate how the brain organizes sensory information to make sense of the world, opening up new frontiers for virtual neuroscience.